Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography

Abstract Background Interleukin-6 (IL-6) plays a central role in atherosclerosis and inflammation. It may improve risk prediction in patients at intermediate cardiovascular risk. Objective To analyze the impact of serum IL-6 in predicting early angiographic coronary artery disease in patients at int...

Full description

Bibliographic Details
Main Authors: Marco V. Wainstein, Márcio Mossmann, Gustavo N. Araujo, Sandro C. Gonçalves, Gabriela L. Gravina, Marlei Sangalli, Francine Veadrigo, Roselene Matte, Rejane Reich, Fernanda G. Costa, Michael Andrades, Antônio Marcos V. da Silva, Marcello C. Bertoluci
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13098-017-0266-5
_version_ 1818191102085169152
author Marco V. Wainstein
Márcio Mossmann
Gustavo N. Araujo
Sandro C. Gonçalves
Gabriela L. Gravina
Marlei Sangalli
Francine Veadrigo
Roselene Matte
Rejane Reich
Fernanda G. Costa
Michael Andrades
Antônio Marcos V. da Silva
Marcello C. Bertoluci
author_facet Marco V. Wainstein
Márcio Mossmann
Gustavo N. Araujo
Sandro C. Gonçalves
Gabriela L. Gravina
Marlei Sangalli
Francine Veadrigo
Roselene Matte
Rejane Reich
Fernanda G. Costa
Michael Andrades
Antônio Marcos V. da Silva
Marcello C. Bertoluci
author_sort Marco V. Wainstein
collection DOAJ
description Abstract Background Interleukin-6 (IL-6) plays a central role in atherosclerosis and inflammation. It may improve risk prediction in patients at intermediate cardiovascular risk. Objective To analyze the impact of serum IL-6 in predicting early angiographic coronary artery disease in patients at intermediate cardiovascular risk with chest pain. Methods In a cross-sectional study, patients referred for coronary angiography due to suspected coronary artery disease (CAD) were included. Coronary artery disease was defined as the presence of at least 30% stenosis in one or more coronary artery. Severity of CAD was classified by the anatomic burden score. Performance of serum IL-6 assay was compared with ACC/AHA atherosclerotic cardiovascular disease (ASCVD) risk score and hs-CRP through receiver operating characteristic (ROC) curves. Results We have included 48 patients with a mean 10-year ASCVD risk of 10.0 ± 6.8%. The prevalence of CAD was 72.9%. The presence of CAD was associated with higher mean levels of IL-6 (p = 0.025). Patients with CAD had significantly more overweight than subjects without CAD. In 27% of patients, IL-6 was >1.0 pg/mL and 100% of these patients had CAD, while only 64% in those with IL-6 <1.0 pg/mL, corresponding to a positive predictive value of 100% (p = 0.015). The area under the receiver operating characteristic (ROC) curve of IL-6, hs-CRP and ASCVD were respectively 0.72, 0.60 and 0.54. Intermediate risk patients with IL-6 >1.0 pg/mL were further reclassified into ASCVD high risk due to the presence of coronary lesions. Conclusion In intermediate risk patients referred for coronary angiography, a serum IL-6 level above 1 pg/mL is predictive of significant CAD. IL-6 determination may be useful to reclassify ASCVD intermediate risk patients into higher risk categories.
first_indexed 2024-12-12T00:09:16Z
format Article
id doaj.art-4ce2928c29a54125a94056aa311358a0
institution Directory Open Access Journal
issn 1758-5996
language English
last_indexed 2024-12-12T00:09:16Z
publishDate 2017-09-01
publisher BMC
record_format Article
series Diabetology & Metabolic Syndrome
spelling doaj.art-4ce2928c29a54125a94056aa311358a02022-12-22T00:45:02ZengBMCDiabetology & Metabolic Syndrome1758-59962017-09-01911710.1186/s13098-017-0266-5Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiographyMarco V. Wainstein0Márcio Mossmann1Gustavo N. Araujo2Sandro C. Gonçalves3Gabriela L. Gravina4Marlei Sangalli5Francine Veadrigo6Roselene Matte7Rejane Reich8Fernanda G. Costa9Michael Andrades10Antônio Marcos V. da Silva11Marcello C. Bertoluci12Programa de Pós-Graduação em Medicina: Cardiologia, Universidade Federal do Rio Grande do SulPrograma de Pós-Graduação em Medicina: Cardiologia, Universidade Federal do Rio Grande do SulPrograma de Pós-Graduação em Medicina: Cardiologia, Universidade Federal do Rio Grande do SulPrograma de Pós-Graduação em Medicina: Cardiologia, Universidade Federal do Rio Grande do SulFaculdade de Medicina da, Universidade Federal do Rio Grande do SulFaculdade de Medicina da, Universidade Federal do Rio Grande do SulFaculdade de Medicina da, Universidade Federal do Rio Grande do SulServiço de Cardiologia do, Hospital de Clínicas de Porto AlegreServiço de Cardiologia do, Hospital de Clínicas de Porto AlegreServiço de Cardiologia do, Hospital de Clínicas de Porto AlegreUnidade de Análises Moleculares e de Proteínas (UAMP), Hospital de Clinicas de Porto AlegreDepartamento de Fisioterapia e Reabilitação, Universidade Federal de Santa MariaServiço de Medicina Interna do, Hospital de Clínicas de Porto AlegreAbstract Background Interleukin-6 (IL-6) plays a central role in atherosclerosis and inflammation. It may improve risk prediction in patients at intermediate cardiovascular risk. Objective To analyze the impact of serum IL-6 in predicting early angiographic coronary artery disease in patients at intermediate cardiovascular risk with chest pain. Methods In a cross-sectional study, patients referred for coronary angiography due to suspected coronary artery disease (CAD) were included. Coronary artery disease was defined as the presence of at least 30% stenosis in one or more coronary artery. Severity of CAD was classified by the anatomic burden score. Performance of serum IL-6 assay was compared with ACC/AHA atherosclerotic cardiovascular disease (ASCVD) risk score and hs-CRP through receiver operating characteristic (ROC) curves. Results We have included 48 patients with a mean 10-year ASCVD risk of 10.0 ± 6.8%. The prevalence of CAD was 72.9%. The presence of CAD was associated with higher mean levels of IL-6 (p = 0.025). Patients with CAD had significantly more overweight than subjects without CAD. In 27% of patients, IL-6 was >1.0 pg/mL and 100% of these patients had CAD, while only 64% in those with IL-6 <1.0 pg/mL, corresponding to a positive predictive value of 100% (p = 0.015). The area under the receiver operating characteristic (ROC) curve of IL-6, hs-CRP and ASCVD were respectively 0.72, 0.60 and 0.54. Intermediate risk patients with IL-6 >1.0 pg/mL were further reclassified into ASCVD high risk due to the presence of coronary lesions. Conclusion In intermediate risk patients referred for coronary angiography, a serum IL-6 level above 1 pg/mL is predictive of significant CAD. IL-6 determination may be useful to reclassify ASCVD intermediate risk patients into higher risk categories.http://link.springer.com/article/10.1186/s13098-017-0266-5Interleukin-6Risk factorsRisk scoresCoronary angiographyInflammationCoronary artery disease
spellingShingle Marco V. Wainstein
Márcio Mossmann
Gustavo N. Araujo
Sandro C. Gonçalves
Gabriela L. Gravina
Marlei Sangalli
Francine Veadrigo
Roselene Matte
Rejane Reich
Fernanda G. Costa
Michael Andrades
Antônio Marcos V. da Silva
Marcello C. Bertoluci
Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
Diabetology & Metabolic Syndrome
Interleukin-6
Risk factors
Risk scores
Coronary angiography
Inflammation
Coronary artery disease
title Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
title_full Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
title_fullStr Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
title_full_unstemmed Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
title_short Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
title_sort elevated serum interleukin 6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
topic Interleukin-6
Risk factors
Risk scores
Coronary angiography
Inflammation
Coronary artery disease
url http://link.springer.com/article/10.1186/s13098-017-0266-5
work_keys_str_mv AT marcovwainstein elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT marciomossmann elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT gustavonaraujo elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT sandrocgoncalves elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT gabrielalgravina elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT marleisangalli elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT francineveadrigo elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT roselenematte elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT rejanereich elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT fernandagcosta elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT michaelandrades elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT antoniomarcosvdasilva elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography
AT marcellocbertoluci elevatedseruminterleukin6ispredictiveofcoronaryarterydiseaseinintermediateriskoverweightpatientsreferredforcoronaryangiography